Global LAG 3 Antibody FDA Approval Clinical Trials LAG 3 Inhibitors Market Future Growth Opportunity Insight
04 oct. 2024 06h57 HE
|
KuicK Research
Delhi, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Global LAG-3 Inhibitors Market, Drug Sales, & Clinical Trials Insight 2029 Report Highlights: Global LAG-3 Inhibitors Market Opportunity: > USD 3...
Global mRNA Cancer Vaccine Clinical Trial FDA Approval Market Size Future Opportunity Companies Insight
04 oct. 2024 06h55 HE
|
KuicK Research
Delhi, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Global mRNA Cancer Vaccines Clinical Trials and Market Future Outlook 2024 Report Highlights: mRNA Cancer Vaccines In Clinical Trials: > 60...
Anti CD70 Antibodies Clinical Trials FDA Approval CD70 Cancer Therapies Clinical Trials Market Opportunity Insight
04 oct. 2024 06h47 HE
|
KuicK Research
Delhi, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Global CD70 Targeting Therapies Market Opportunity and Clinical Trials Insight 2024 Report Highlights: CD70 Targeting Therapies In Clinical Trials: > 20...
Global Bispecific Antibodies Clinical Trials Market Size FDA Approved Bispecific Antibodies Insight
26 sept. 2024 06h52 HE
|
KuicK Research
Delhi, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Market, Drugs Sales, Patent, Price and Clinical Trials Insight 2029 Report Highlights: Bispecific Antibodies Development...
CD47 Targeted Cancer Immunotherapy Drugs Clinical Trials FDA Approval Insight
26 sept. 2024 06h09 HE
|
KuicK Research
Delhi, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Global CD47 Inhibitor Drug Clinical Trials Insight & Market Opportunity Outlook 2028 Report Highlights Global & Regional Market Opportunity...
SKB264 Innovative Cancer Antibody Drug Conjugate Clinical Trials Efficacy Insight
19 sept. 2024 07h34 HE
|
KuicK Research
Delhi, Sept. 19, 2024 (GLOBE NEWSWIRE) -- SKB264, also known as MK-2870, is an innovative antibody-drug conjugate (ADC) targeting TROP2, currently being developed by Kelun Biotech in partnership...
Bispecific Antibody Drug Conjugates Clinical Trials Insight
17 sept. 2024 07h14 HE
|
KuicK Research
Delhi, Sept. 17, 2024 (GLOBE NEWSWIRE) -- The global market for bispecific antibody-drug conjugates (BsADCs) has experienced remarkable expansion, attributed to their revolutionary capabilities in...
Bispecific Antibody Drug Conjugates Clinical Trials FDA Approval Commercial Launch Market Forecast 2029
12 sept. 2024 07h49 HE
|
KuicK Research
Delhi, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Drug Conjugates Clinical Trials, Regulatory Approvals & Future Market Opportunity Outlook 2029 Report: Report Answers...
Bispecific Antibody Drug Conjugates Mechanism of Action In Cancer Therapy
09 sept. 2024 23h00 HE
|
KuicK Research
Delhi, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Drug Conjugates Clinical Trials Patents Commercial Opportunity Insight Report Highlights: Report Answers Question On Why There...
Clinical Trials In Turkey
09 sept. 2024 14h35 HE
|
KuicK Research
Delhi, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Turkey Cancer Drugs Clinical Trials Insight 2024 Report Offering: Turkey Clinical Trials Market Opportunity 2024 and 2030 (In US$ Million)Clinical Trials...